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Abstract
Background: Oncological patients often feel left out of important treatment decisions. However, when physicians
engage them in shared decision-making (SDM), patients benefit in many ways and the situation is improved. SDM
can effectively be taught to physicians, but participation barriers for SDM physician group trainings are high, making it
hard to convince physicians to participate.
With this in mind, we aim to develop and evaluate two new dissemination strategies for a brief, SDM training program
based upon a proven SDM group-training concept: an individualized context-based SDM face-to-face training (IG I) and
a web-based interactive SDM online training (IG II).
We aim to analyze which improvements can be achieved by IG I and II compared to a control group (CG) in physician
SDM competence and performance as well as the impact on the physician-patient relationship. Furthermore,
we analyze differences in satisfaction concerning the two dissemination strategies by means of a training evaluation.
Methods/design: We examine – based on a three-armed randomized controlled trial (IG I, IG II, CG) – the effectiveness
of two new dissemination strategies for a SDM training program compared to a CG receiving no SDM training
(voluntary access to SDM training as an incentive for participation after completion of the study). We aim to include 162
physicians randomized to one of the three arms. There will be two assessment points in time (before intervention: T0 and
post-training: T1). The main outcome is the SDM competence of physicians as measured by an established observational
assessment rating system (OPTION-12) by means of consultations with Standardized Patients. Standardized Patients are
individuals trained to act as “real” patients. Secondary outcome measures are the SDM performance (SDM-Q-9) and the
Questionnaire on the Quality of Physician-Patient-Interaction (QQPPI) both rated by Standardized Patients as well as the
physicians’ training evaluation.
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Discussion: This trial will assess the effectiveness and acceptability of two new dissemination strategies for a brief, SDM
training program for physicians. Opportunities and challenges regarding implementation in daily routines will be discussed.
Trial registration: ClinicalTrials.gov, Identifier: NCT02674360. Prospectively registered on 4 February 2016.
Keywords: Shared decision-making, Randomized controlled trial, Oncology, Web-based online training, Coaching,
Standardized patients
Background and rationale
Different studies have revealed that cancer patients do not
feel sufficiently involved in important treatment decisions
[1, 2]. Patients often feel that physicians decide in a too
paternalistic way and do not consider the patient’s per-
sonal life situation, expectations, preferences and fears.
Patients who experienced paternalism were less satisfied
with the consultation and emotional support [3].
An attempt to overcome those shortcomings in patient-
physician communication is the implementation of the
model of shared decision-making (SDM) into routine care.
SDM is seen as an ideal model for how physicians and pa-
tients should interact in medical decision-making [4]. In
this concept, both the patient’s medical and personal infor-
mation are shared between physician and patient, and both
parties (in an equal position) subsequently come to a
shared decision as a team. Implementation of SDM re-
quires that the physician has a patient-centered attitude
and is open to the needs of the patient.
A review by Chewning et al. [5] about role preferences
in medical decision-making showed a trend to an in-
creasing demand for SDM by patients in recent years.
Studies indicate that if SDM is implemented, patients
show a higher level of treatment satisfaction [6–8], a
higher level of risk comprehension, less decisional con-
flict [9], more realistic expectations towards the therapy
[10], a higher level of treatment adherence and better
coping with illness [11]. Furthermore, a higher quality of
physician-patient interaction can be achieved [12].
Despite physicians’ positive attitude towards SDM
[13], implementation in daily practice is insufficient (e.g.,
[14, 15]), as there are many barriers such as time con-
straints, patient characteristics and the nature of the
clinical situation [16].
In recent years, there has been a growing number of
SDM training programs for physicians [17] which teach
them how to involve their patients in important treat-
ment decisions [18, 19]. However, it remains unclear
what kind of intervention is most effective to enhance
physician competence at SDM [20].
Earlier studies have shown that it is difficult to enroll
physicians for an SDM training intervention that occurs
in an external setting. Especially, economic and psycho-
logical factors seem to represent the major barriers [18].
Moreover, physicians frequently overestimate their own
communication skills [21], which consequently leads to
an unwillingness to spend time participating in commu-
nication trainings.
Because of these circumstances, it has been suggested
that new SDM training strategies might be necessary
that can be administered independently of time and
place: e.g., individualized, context-based, face-to-face
SDM trainings or web-based online SDM trainings con-
stitute possible alternatives for common SDM group-
based trainings [18, 22] and could potentially address
physicians’ temporal and locational constraints that
have previously inhibited participation.
Context-based communication trainings for physicians
have achieved good results in the improvement of physi-
cians’ communication skills in clinical encounters [21,
23, 24]. Moreover, from the physicians’ point of view,
face-to-face interventions have some advantages: They
feel less undermined in their expert role, and their exist-
ent communication skills are recognized [21].
Web-based trainings are effective opportunities for
physician education [25–28]. The challenge in develop-
ing SDM online trainings consists in providing practical
(procedural) and not merely factual (declarative) know-
ledge [25, 29, 30]. There is evidence that well-designed
online tutorials facilitate the acquisition of complex skills
as well as reduce time in the acquisition of these skills
compared to traditional formats such as personal lec-
tures (e.g., [31]). Well-designed online trainings show
advantages regarding time efficacy and memory effects
compared to traditional teaching methods such as
frontal presentations [32, 33], which seem to be effective
in improving knowledge but less effective in changing
behavior [34, 35].
However, when compared to web-based trainings, face-
to-face trainings generally seem to be more effective [26].
This study protocol was written in accordance with
the Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) guidelines. The SPIRIT
Checklist has been included in Additional file 1.
Objectives
The current study aims to develop and evaluate two in-
novative dissemination strategies for a brief, SDM train-
ing program for physicians. Based on an established and
evaluated comprehensive SDM group training concept
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[18], we adapt an individualized, context-based, SDM,
face-to-face training (intervention group I: IG I) and a
web-based interactive SDM online training (intervention
group II: IG II). We aim to evaluate which improve-
ments in physician SDM competence and performance
can be achieved by these two interventions compared to
a control group (CG) without SDM training and if the
quality of physician-patient interaction is influenced.
SDM competence and performance as well as physician-
patient interaction are assessed in consultations with
Standardized Patients (SPs) before and after the inter-
vention. SPs, also known as simulated patients, are indi-
viduals trained to act as “real” patients in order to
simulate a set of symptoms or problems in a clinical sce-
nario in a standardized way, allowing direct comparison
of the physicians’ SDM and communication skills.
We derive the following hypotheses:
Main hypothesis
Hypothesis 1 We hypothesize that in both intervention
groups (IG I and II), physicians will show a higher level of
external-rated SDM competence (assessed by OPTION-
12 [36–38]; adjusted for T0) during their consultation with
an SP 4 weeks after the training session (T1) compared to
a CG (no training).
Secondary hypotheses
Hypothesis 2 In both intervention groups (IG I and II),
physicians will show a higher level of SDM perform-
ance (assessed by SDM-Q-9 [39, 40]; adjusted for T0)
rated by an SP during consultation 4 weeks after the
training session (T1) compared to physicians in the CG
(no training).
Hypothesis 3 In both intervention groups (IG I and II),
physicians will show a higher level of quality in their
physician-patient interaction (assessed by the Question-
naire on the Quality of Physician–Patient Interaction
(QQPPI) [41]; adjusted for T0) rated by an SP during
consultation 4 weeks after the training session (T1) com-
pared to physicians in the CG (no training).
Hypothesis 4 Physicians receiving the individualized
context-based SDM face-to-face training (IG I) will be
more satisfied with the training (assessed by self-devel-
oped training evaluation) compared to physicians receiv-
ing the web-based interactive SDM online training (IG
II).
Trial design
The study uses a bicentric, three-armed, randomized con-
trolled, pre-post design. We will include 162 physicians
who work either with colon cancer patients (stage II with
risk factors) or breast cancer patients (stage II). In these
two stages of disease patients are confronted with highly
preference-sensitive decisions: For colon cancer stage II
with risk factors (e.g., after an emergency surgery, perfor-
ation of the tumor, poorly differentiated tumor tissue) the
German medical guidelines [42] recommend the use of
SDM concerning the decision for or against chemotherapy
after the surgical excision of the tumor. For stage II breast
cancer the German medical guidelines [43] recommend
SDM to choose between two possible options: breast-con-
serving surgery followed by obligatory postoperative
radiotherapy or, alternatively, a complete removal of the
breast. In each of the two IGs and in the CG, we aim to
include 54 physicians. The study design and participant
timeline are shown in detail in Fig. 1.
Methods: Participants, interventions, and
outcomes
Study setting
Both study centers are responsible for physician recruit-
ment and administration of SDM trainings; the Univer-
sity Medical Center of Heidelberg (HD) is responsible
for the southern part of Germany, and the University
Medical Center Hamburg-Eppendorf (HH) is responsible
for the northern part. Physicians from many different
backgrounds are included, assuming that they meet the
eligibility criteria.
Eligibility criteria
Inclusion/exclusion I: Physicians who work with colon
or breast cancer patients will be included in the study.
Furthermore, physicians are required to have Internet
access, to sign a letter of consent for participating in the
study and to agree to videotape their consultations with
the SPs. Physicians who are not attending to oncological
patients will be excluded from the study.
Inclusion/exclusion II: Physicians who fill out the on-
line questionnaire for inclusion, but then do not conduct
the consultation at T0 are defined as withdrawal. With-
drawal physicians are compared regarding sex, medical
specialty, and years of professional experience with those
participants who conduct consultations at T0 or T0 and
T1. Those comparisons will be done using t and chi
2
tests to identify a potential systematic withdrawal. With-
drawal physicians will not be analyzed further and will
be excluded.
Interventions
The intervention consists of a brief, SDM training pro-
gram for physicians, either in the form of an individual-
ized, context-based SDM face-to-face training in the
physician’s office (IG I) or as an interactive, web-based,
SDM online training (IG II). The CG of physicians
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receives no SDM training during the course of the study,
but is granted voluntary access to SDM online training
as an incentive for participation after completion of T1.
The content of both trainings (IG I and II) follows a
comprehensive SDM training program previously de-
veloped and evaluated by the same study group [44]. It
has recently been applied by other study groups [45].
However, in the present study SDM training content is
shortened, condensed and adapted to the new dissem-
ination methods.
Content relies on SDM and patient-centered commu-
nication. The learning objectives for participating physi-
cians are:
 Knowledge of the theoretical basis of SDM
 Recognizing the participation needs of their patients
 Knowledge of techniques for an adequate transfer of
information, risk communication, and performance
of SDM during consultations
 Consultation structuring skills
Both new training strategies are interactive in charac-
ter and participants are actively taking part. For instance,
physicians are asked to define their own goals and the
competences they want to achieve by the training. Also
feedback is a fundamental component of both training
strategies, enabling participants to constantly compare
their aims and their current position [46], either by feed-
back given by the coach or with a self-rating using a reli-
able instrument (OPTION-12, German version; [36]).
The difference between the two training strategies is
the method of the teaching procedures. In both IGs, the
trainings have the same length (approximately 1.5 h).
The trainings within the study are being offered free of
charge for all participating physicians (including CG).
We evaluate the treatment integrity for both training
strategies using an online survey (10 general items ap-
propriate to both implementation strategies and four
items specific for the web-based training or resp. five
items specific for the face-to-face training. All specific
items pertain either to specific interventions, exercises,
Fig. 1 Study design
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work atmosphere, trainers' responsiveness or design
of the two different training strategies.) send to the par-
ticipants of the IG I and II after the training but prior to
the second consultation with the SP at T1. The online
survey assesses physicians’ satisfaction with content and
realization of the trainings. In addition, in IG II, the
evaluation of the user profiles (logfiles) will serve to as-
sess adherence to the web-based training in IG II.
Face-to-face-training (IG I)
The individualized, context-based, face-to-face training
follows the coaching principle. Participants receive the
coaching module at their workplace with a coach/trainer
from the project team. Prior to face-to-face training, the
coach assesses the videotaped consultation with the first
SP. During the face-to-face training, the coach provides
feedback, reminds the participant of possible missed steps
during his videotaped consultation and, if needed, demon-
strates specific SDM steps. Favorable behavior is marked
and reinforced and improvable behavior suggested and
practiced. Finally, individual goals for improvement and
practice are agreed on and fixed. Additionally, participants
receive a booklet that they may keep, summarizing all rele-
vant information on SDM. Two weeks later, the participat-
ing physician receives a booster session via telephone from
their coach (maximum 30min). In this booster session, it is
assessed how the participant was able to put SDM into
action, and the remaining questions and personal
SDM-related goals of the participant are discussed.
The quality and consistency of the face-to-face training
will be ensured through the regular internal supervision
and training of participating SDM coaches/trainers.
After each face-to-face intervention, the trainer com-
pletes a protocol of the intervention.
Web-based training (IG II)
The SDM online training is based on the modeling
principle. Participating physicians learn by watching
educational video clips in which SDM is performed to a
very high standard by lay actors, namely, a very experi-
enced senior physician functioning as a role model (i.e.,
head of the Breast Center) and a SP. This helps partici-
pating physicians develop their own mental model of the
essential SDM steps and subsequently utilize them. In
technical terms, the online training is conceptualized as
a tutorial program [47]. The sequence is identical for
every unit: introduction, presentation of the information,
tasks, analysis of the answers, feedback, and conclusion
of the unit [48]. There is no rigid order; each participat-
ing physician can adapt the individual units to his own
needs. After watching his own videotaped consultation
with a SP (DVD sent to the participant before), the phys-
ician is subsequently asked to rate his own performance
by the OPTION-12 rating system (identical to the rating
system the external raters use). Unit-related tasks in dif-
ferent formats (e.g., multiple choice questions and open
questions) serve to underpin the intended learning
process. One objective consists of conveying knowledge
about how to encourage patients to take an active part
in the decision-making process.
The online tutorial consists of four units: background
of SDM (theoretical framework), presentation and ex-
planation of the six SDM steps (illustrated by video clips
established by the project team), the basic principles of
risk communication in medicine, and the basic princi-
ples of communication skills. This tutorial system is in-
tegrated in an established learning platform (Moodle).
Control group (CG)
Physicians randomized to the CG receive no SDM inter-
vention during the study period. However, as an incen-
tive for study participation, they are offered access to the
web-based SDM online training and receive a booklet
summarizing all relevant information on SDM at the
end of the study (after finishing T1).
Standardized Patients (SPs)
As it is difficult to include real patients in randomized
controlled trial (RCT) interventions, we decided to use
SPs. In German- and English-speaking countries, SPs
often play a crucial role in the assessment of communi-
cation skills in medicine [49, 50]. SPs are mostly lay ac-
tors who are trained to simulate a real patient in a
standardized way [51]. The standardization of the patient
role allows comparison of the physicians SDM perform-
ance in a most effective way.
Training of the SPs
The role training for the SPs was conducted by an expe-
rienced professional trainer for actors who oversees the
SP unit at the medical faculty in HD. In cooperation
with oncologists, we developed three case vignettes for
colon cancer (three male roles) and four for breast can-
cer (four female roles). The vignettes aim to represent
an average cancer patient at an average diagnostic and
treatment difficulty level for the physicians and to avoid
special or difficult circumstances.
We will offer regular meetings for the SPs with the pro-
ject team to discuss potential problems emerging during
their encounters with the physicians. Furthermore, we
want to ensure that no SP comes in personal conflict with
his role as a cancer patient. Our professional trainer for
actors will also stay in close contact with the SPs during
the duration of the study and will give additional training
lessons if needed. To reassure the standardization of the
encounters and be able to intervene early when aberra-
tions are obvious, the project team watches the videotaped
consultation after the SP returns from the physician.
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Procedure of the SP consultations
A member of the project team contacts the participating
physician via telephone or e-mail to make an appoint-
ment for the consultation with the SP. A SP is then se-
lected by availability and fit between diagnosis of case
vignettes and the physicians’ field of work (colon or
breast cancer). Care is taken to send different SPs with
different case vignettes at T0 and T1 per physician. All
physicians are aware that the consultation takes place
with SPs and not with real patients. One week before
the consultation the physician receives a letter including
the medical information of the fictitious patient (e.g.,
size of the tumor, etc.). Furthermore, the physician re-
ceives information material about the available treatment
options and also information about the recurrence prob-
ability of the particular disease (colon or breast cancer).
This is to ensure basic knowledge also for less experi-
enced physicians. The consultation takes place at the
working place of the physician and is videotaped by the
SP via a tablet computer. After the consultation, the SP
gives out a paper questionnaire to the physician and
completes his own questionnaire and subsequently
brings the questionnaires as well as the tablet with the
videotaped consultation back to the project team.
Recruitment of SPs
To provide the necessary amount of SP contacts, we need
at least 12 SPs (six in each study center) who are recruited
via notice boards and online via university web-sites. SPs
must meet the following inclusion criteria:
 Age range 40 to 65 years for female (breast cancer
vignettes) SPs and 50 to 75 years for male (colon
cancer vignettes) SPs (relying on the approximate
onset of the diseases)
 Fluent in German
 Flexible availability
 Mobility either by train or by car (costs will be
refunded)
 Guaranteed participation for a period of at least
1.5 years
 No cancer disease in the own history or in the family
Outcomes
Overall schedules of enrollment, interventions, and as-
sessments can be found in Fig. 2.
Primary outcome
As primary outcome for hypothesis 1 the German version
of the OPTION-12 scale (Observing Patient Involvement
12; 36, 37, 38 References are not "active") is used. The
OPTION-12 scale assesses the physicians’ SDM compe-
tence in consultations. The OPTION-12 scale is a
well-established external, rater-based observing method
for assessing the process of shared decision-making [52].
It has a good reliability with a value of 0.79. The consulta-
tions with the SPs are rated based on 12 criteria. Examples
for each rating category per item will be determined be-
forehand. Each consultation is rated by two blinded and
independent, well-trained raters using videotapes and
transcriptions of the films. The mean value of both raters
will be used. Furthermore, to describe interrater-reliability,
Cohen’s Kappa will be computed.
Secondary outcomes
To test hypothesis 2 we use the validated German ver-
sion of the SDM-Q-9 (Fragebogen zur Partizipativen
Entscheidungsfindung; Engl. Shared Decision Making
Questionnaire-9 – Patient Version; [40, 53]). The
SDM-Q-9 assesses SDM performance in nine items from
the perspective of SPs. Furthermore, to test hypothesis 3
we use the validated German version of the QQPPI (Fra-
gebogen zur Arzt-Patienten-Interaktion (FAPI); Engl.
Questionnaire on the Quality of Physician-Patient Inter-
action; [41]). The QQPPI assesses the quality of the
physician-patient interaction from the patient’s perspec-
tive. The questionnaire includes 14 items related to ad-
equate information transfer, involvement in decisions
and the patient’s perception of being taken seriously by
the physician. To test hypothesis 4 regarding participat-
ing physicians’ satisfaction with the training we will use
a self-developed training evaluation with 10 general
items appropriate to both implementation strategies.
This questionnaire is also used to control the treatment
integrity and is implemented as an online questionnaire
using the software SoSci Survey (www.soscisurvey.de);
see for detailed description “Interventions.”
Further measurements
We assess sociodemographic data and profession-re-
lated variables (sex, work setting, years of professional
experience) by a self-developed online questionnaire
using the software Social Science Survey (SoSci Survey)
(www.soscisurvey.de). Further measurements at differ-
ent time points for physicians and SPs will be inte-
grated in this study. However, because these outcomes
are not the focus of the hypotheses of this study proto-
col, they will not be described further.
Sample size
The sample size calculation is based on the main hypoth-
esis1 and the method of analysis. A review of the efficacy of
non-web-based SDM interventions [54] including five
RCTs described significant comparisons in two of the five
studies. In the significant studies, effect sizes were calcu-
lated as d = 1.06 and d = 2.11. Taking the non-significant re-
sults into account, a conservative estimation of effect size
seems appropriate. Further, according to a meta-analysis
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[26], web-based trainings for physicians achieved high-
range effect sizes regarding skills (Hedges’ g = 0.85) and be-
haviors/effects on patient care (Hedges’ g = 0.82). Therefore,
an effect size of d = 0.50 is expected for the primary out-
come (SDM competence assessed by OPTION-12 at T1 ad-
justed for SDM competence at T0).
The estimation of the sample size for a covariance-
analysis (ANCOVA) is comparable to an analysis of vari-
ance (ANOVA) focusing on the difference between ad-
justed means. A power analysis via GPower Version
3.1.2 [55] for an ANOVA (one factor with three groups:
IG I, IG II, CG) was performed. The results show with a
type-1 error of 5% a sample size of 159 physicians is
needed to detect a statistically significant effect size of
d = 0.50 with a power of 80%. Due to randomization is-
sues, a sample size of 162 participants is targeted.
Recruitment
Each study center will establish lists of physicians through-
out Germany working with colon or breast cancer patients,
either in cancer centers or as practitioners, by a systematic
Internet research and using the lists of federal statutory
physicians’ associations (Kassenärztliche Vereinigungen).
We will subsequently send postal invitations to participate,
provide flyers to each center’s responding practitioner and
have a reference on our webpage that provides detailed in-
formation about the study. If e-mail addresses are available,
we will send the invitation for participation in a digital for-
mat. Furthermore, if preferred (e.g., from a head of a cancer
center), we will attend the cancer center and introduce the
study and the corresponding SDM training program
personally. Interested physicians are asked to contact
the project team via e-mail or telephone. The respon-
sible project team subsequently sends an e-mail includ-
ing the link for the first online questionnaire to the
participant and allocates a code to each participant in a
consecutive numerical order.
Methods: Assignment of interventions
Sequence generation
Randomization will be conducted by a computer-gen-
erated block-randomization performed by the open
source randomization software Randi3 [56]. The
randomization is stratified by study center and blocked
into three randomization blocks (per study center)
with 27 participants (nine per IG I, II and CG) to guar-
antee equal sample sizes in each of the three groups
when targeted sample size is not achieved (2 study
center × 3 randomization blocks × 3 groups × 9 partici-
pants = 162 participants).
Fig. 2 Schedule of enrollment, interventions, and assessments (Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Figure)
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Allocation concealment mechanism
The code of the participating physicians will be random-
ized after the first consultation with the SP (T0). For this,
both study centers send the code for randomization to a
study nurse per e-mail, who conducts the computer-gen-
erated randomization and informs the study centers about
the result per e-mail.
Implementation
The project team provides the result of the randomization
to the participant by e-mail and coordinates the next steps
in accordance to the result. For participants randomized
to IG I, an appointment for the face-to-face-training is ar-
ranged, for participants of the IG II and CG an appoint-
ment for T1 is arranged and additionally for participants
of IG II a link for the web-based interactive SDM online
training is sent per e-mail.
Blinding
Due to the nature of this trial, blinding of the physicians
is not feasible. However, SPs and the independent raters,
when rating the videotaped and transcribed consulta-
tions, are blinded regarding the group (IG I, IG II, CG)
and the point of measurement (T0, T1).
Methods: Data collection, management, and
analysis
Data collection methods
Before we include participants we will assess sociodemo-
graphic and profession-related data (medical specialization,
years of professional experience) through the online survey
for participating physicians. After a consultation with the
SP, both the SP and the physician obtain a set of
paper-based questionnaires (in T0 and T1). Consultations
between the physician and the SP are recorded on video
(by the SPs) and subsequently assessed by the research
team. The evaluation of the intervention is conducted with
an online survey after finishing either face-to-face (IG I) or
online-training (IG II). In the case that participants fail to
complete an online questionnaire, the project team sends a
reminder via e-mail.
Data management
Data management occurs in the study centers, and each
center is responsible for its own data. Data entry will be
conducted by study assistants. We aim to conduct recip-
rocal random checks on the quality of data entry. At the
end of data collection, the data sets will be pooled for
final analyses.
Statistical methods
Statistical analyses
To test the main hypothesis 1 an ANCOVA is con-
ducted. The mean of the OPTION-12 at T1 serves as
the dependent variable and the group factor (IG I, IG II,
CG) serves as independent variable. The mean of the
OPTION-12 at T0 serves as a covariate. Post-hoc tests
using a Bonferroni correction will be conducted to analyze
single contrasts. To test the secondary hypotheses 2 and 3,
two ANCOVAS and post-hoc tests, comparable to the
ANCOVA for hypothesis 1, will be conducted with the
means of the SDM-Q-9 and QQPPI at T1 as dependent
variable, the group as independent variable and the means
of SDM-Q-9 and QQPPI at T0 as covariates. To test hy-
pothesis 4 regarding the satisfaction a t test for independ-
ent groups with IG I and II as independent variable and
the mean of the 10 general items of the training evaluation
as dependent variable will be conducted. For data manage-
ment and analyzing, SPSS© will be used.
Drop-outs and missing values
Participants, who drop out after T0, are considered for the
main outcome (OPTION-12, no missing values at T0 due
to inclusion/exclusion criteria II and nature of external
rating) according to the intention-to-treat principle using
a single imputation method, in more detail we impute the
mean difference of other group (MOTH-D) [57]. There-
fore, the mean difference (per item) between T1 and T0 of
available cases in CG is added to T0 of drop-outs in IG I
and II and vice versa the mean difference (per item) in IG
I and II is added to T0 of drop-outs in CG. Additionally,
an analysis with available cases which completed the study
(analysis per protocol) will be reported in contrast.
Missing data in the ratings of the SPs (SDM-Q-9 and
QQPPI; secondary outcome) due to drop-outs will be
handled like the main outcome using MOTH-D. Add-
itionally if missing data in a single item occurs in more
than 50% of all questionnaires (T0 and T1) of available
cases, this item will be deleted for all SP ratings because
this item does not fit into the nature of consultations in
this study. It is unlikely that missing values will emerge
to a greater extent as SPs were reminded frequently to
complete the questionnaire completely. However, single
missing values in the SDM-Q-9 and QQPPI will be not
imputed. Instead, a mean value is calculated with the
remaining completed items of the questionnaire.
For analyzing the training evaluation missing cases will
be imputed by the worst possible mean. An analysis with
available cases will be conducted and compared.
Methods: Monitoring
Data monitoring and auditing
The Data Monitoring Committee (DMC) consists of
KG, NM, and ChB in Heidelberg and SD, CB, and MH
in Hamburg. For each of the two recruiting centers re-
ports of data recruitment status will be assessed in a
written report every 3 months by KG and SD and mailed
around to the whole study group. Regular telephone
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conferences every 3 months with all study group mem-
bers participating will serve to discuss improvement
strategies and initiate adjustment strategies in case that
recruitment is delayed.
The DMC is independent of the sponsor. However, the
sponsor (DKH) is controlling for progress in recruitment
by asking for an interim report after the first 2 years of
the grant, and will only grant finances for the third and
last year of the study if recruitment is progressing ac-
cording to plan. Therefore, the sponsor can make the
final decision to stop the trial early after 2 years in case
that milestones are not met by that time point.
Harms, confidentiality and access to data
There are no harms expected for the participating physi-
cians. SPs will be supervised by members of the project
team; relevant adverse events are unlikely. The data pro-
tection provisions of the Federal Data Protection Act are
conformed to in the implementation of the study. The
survey cannot be conducted completely anonymously, due
to the videotaped consultations and the repeated survey
that is required for subsequent analysis. However, data will
be pseudonymized. Subsequent assignment of data to a
person is only possible by means of randomized codes.
The transcripts for each video recording will also be anon-
ymized and identified by the appropriate code.
All information and videotaped consultations will be
kept strictly confidential and no personal data or video-
taped consultation will be passed to third parties. In case
of the publication of results, it will be ensured that no
inference can be made about the identity of participants.
Personal data will be deleted either at the end of the
study or, at the latest, after 5 years.
Discussion
This trial will assess the effectiveness and acceptability of
two innovative SDM training programs for physicians. We
aim to analyze which improvements in SDM competence
can be achieved by these training programs and their im-
pact on the physician-patient interaction and to test if the
dissemination methods differ regarding their efficacy.
Although we aim to meet the needs of the physicians
in their daily routine, we anticipate some challenges in
recruitment for the study. As the training is voluntary, it
cannot be assumed that it can be performed during
working hours. If the participants must complete the
training in their leisure time, this could likely influence
their motivation and, therefore, the expected effects of
the training. Furthermore, face-to-face SDM training will
be conducted by different members of the project team.
Although we intend to standardize the coaching ses-
sions, as far as possible, it cannot be avoided that there
will be some differences between training lessons per-
formed by different trainers. Although we train the SPs
in oncological case vignettes to enable them to act in a
standardized way, every SP brings his own personality and
attitudes to the consultations. Furthermore, it is inevitable
that the SPs will undergo an increase in medical know-
ledge as the study evolves and, therefore, may show a be-
havior change during later consultations. We will try to
compensate for this by strictly monitoring consultations,
and we will give additional training lessons if needed. We
expect in IG I with face-to-face training to gain a higher
level of satisfaction. However, for long-term implementa-
tion of the training, we assume that regarding the tem-
poral expense an online tutorial is more feasible in daily
routine compared to face-to-face coaching lessons. Des-
pite these challenges, we also see several opportunities.
Specifically, we consider our web-based training as an ad-
equate and cost-effective way to convey SDM-related
knowledge and competences. If this hypothesis is vali-
dated, then our training indicates that this training format
should be extended to other medical areas. Furthermore,
we consider our training to be an appropriate way to con-
vey other communication-related challenges (e.g., break-
ing bad news) in daily medical practice.
Trial status
Physician recruitment for the trial started in the fall of
2016 and will last until December 2018.
Additional file
Additional file 1: Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) 2013 Checklist: recommended items to
address in a clinical trial protocol and related documents. (DOC 120 kb)
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